
    
      In a prospective, randomized, interventional, controlled phase IIb clinical the functional
      results of treatment with ranibizumab in patients with macular edema due to branch retinal
      vein occlusion when given according to morphological changes detected by OCT compared to
      standard re-treatment criteria according to SmPC
    
  